Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 23,931 AUPH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 23,931 | n/a |
| Feb 3, 2026 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 53,960 | n/a |
| Nov 24, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax Withholding | 6,039 | $94.7K |
| May 16, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 37,485 | n/a |
| Feb 3, 2025 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 17,950 | n/a |
| Nov 25, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 20,631 | n/a |
| Jan 23, 2024 | Mirati Therapeutics, Inc. (MRTX) | Disposition to Issuer | 6,021 | n/a |
| Jan 19, 2024 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 13,948 | n/a |
| Dec 20, 2022 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 38,580 | n/a |
| Dec 23, 2021 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale | 250 | $2.4K |